AstraZeneca Joins WAIC for First Time to Seek Partners for 10 Healthcare + AI Solutions Jul 3, 2020 Life Science
Healthcare Roundup – Gilead terminates agreement with DURECT, Feds to ship extra remdesivir to U.S. hotspots Jun 26, 2020 Technology
Healthcare Roundup – European advisory backs Gilead’s remdesivir for COVID-19, Ekso Bionics shares rocket Jun 25, 2020 Life Science
Healthcare Roundup –Texas Governor warns on COVID-19, Curaleaf to acquire Grassroots Jun 23, 2020 Life Science
Healthcare Roundup – AbbVie nixes microbiome GI program collaboration, Alpha Pro Tech pops Jun 18, 2020 Life Science
Healthcare Roundup – COVID-19 treatment, economic news push futures even higher, COVID hospitalizations on the rise in Texas Jun 17, 2020 Life Science
Replicel life Sciences Inc. Announces Application for a Management Cease Trade Order Jun 15, 2020 Life Science
Healthcare Roundup – CDC warns on another round of lockdowns, AbbVie thumbs down on discounted mini-tender for shares Jun 12, 2020 Life Science
Healthcare Roundup – Inovio to begin Phase 1/2 trial of COVID-19 DNA vaccine, Roche’s severe COVID-19 test scores FDA approval Jun 4, 2020 Life Science
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors Jun 3, 2020 Life Science
Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China May 30, 2020 Life Science
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites May 28, 2020 Life Science
Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers May 27, 2020 Life Science
Healthcare Roundup – Merck jumps into COVID-19 arena with three initiatives, Gilead picks up an upgrade on remdesivir upside May 26, 2020 Life Science
Healthcare Roundup – Novavax starts clinical trial of COVID-19 vaccine, Sanofi to shed 20.6% stake in Regeneron May 25, 2020 Life Science
Healthcare Roundup – FDA OKs Takeda’s brigatinib, Pfizer urges noteholders to reject offer by Huguenot Bond Liquidity May 23, 2020 Life Science
